High Throughput Mass Spectrometry-Based Clinical Solution Can Run Hundreds of Samples Per Day APHL Newborn Screening and Genetic Testing Symposium, New Orleans, Booth #409– September 8, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its QSight® 210 MD system, designed to provide routine high... Read more
Provides Families a Novel, Personalized Approach to Managing their Health WALTHAM, Massachusetts – September 7, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 15th annual Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017 at 11:40 am ET at the Grand Hyatt New York. Robert Friel, PerkinElmer’s chairman and chief executive... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Baird Global Healthcare Conference on Wednesday, September 6, 2017 at 10:50 am ET at the InterContinental New York Barclay. Andy Wilson, PerkinElmer’s chief financial officer, will provide an overview... Read more
Download PDF Read more
Download PDF Read more
PerkinElmer Genetics Provides Complete Genomic Lab Testing Solution WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics’ clinical genomics services. Through its integrated laboratories in the U.S., India and China, PerkinElmer offers a global genomic lab testing platform that performs... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, August 3 2017, after market close, the Company will release second quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert... Read more